Literature DB >> 10736161

Enzyme I of the phosphoenolpyruvate:sugar phosphotransferase system. In vitro intragenic complementation: the roles of Arg126 in phosphoryl transfer and the C-terminal domain in dimerization.

S J Brokx1, J Talbot, F Georges, E B Waygood.   

Abstract

Enzyme I mutants of the Salmonella typhimurium phosphoenolpyruvate:sugar phosphotransferase system (PTS), which show in vitro intragenic complementation, have been identified as Arg126Cys (strain SB1690 ptsI34), Gly356Ser (strain SB1681 ptsI16), and Arg375Cys (strain SB1476 ptsI17). The mutation Arg126Cys is in the N-terminal HPr-binding domain, and complements Gly356Ser and Arg375Cys enzyme I mutations located in the C-terminal phosphoenolpyruvate(PEP)-binding domain. Complementation results in the formation of unstable heterodimers. None of the mutations alters the K(m) for HPr, which is phosphorylated by enzyme I. Arg126 is a conserved residue; the Arg126Cys mutation gives a V(max) of 0.04% wild-type, establishing a role in phosphoryl transfer. The Gly356Ser and Arg375Cys mutations reduce enzyme I V(max) to 4 and 2%, respectively, and for both, the PEP K(m) is increased from 0.1 to 3 mM. It is concluded that this activity was from the monomer, rather than the dimer normally found in assays of wild-type. In the presence of Arg126Cys enzyme, V(max) for Gly356Ser and Arg375Cys enzymes I increased 6- and 2-fold, respectively; the K(m) for PEP decreased to <10 microM, but the K(m) became dependent upon the stability of the heterodimer in the assay. Gly356 is conserved in enzyme I and pyruvate phosphate dikinase, which is a homologue of enzyme I, and this residue is part of a conserved sequence in the subunit interaction site. Gly356Ser mutation impairs enzyme I dimerization. The mutation Arg375Cys also impairs dimerization, but the equivalent residue in pyruvate phosphate dikinase is not associated with the subunit interaction site. A 37 000 Da, C-terminal domain of enzyme I has been expressed and purified; it dimerizes and complements Gly356Ser and Arg375Cys enzymes I proving that the association/dissociation properties of enzyme I are a function of the C-terminal domain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10736161     DOI: 10.1021/bi991250z

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

Review 1.  How phosphotransferase system-related protein phosphorylation regulates carbohydrate metabolism in bacteria.

Authors:  Josef Deutscher; Christof Francke; Pieter W Postma
Journal:  Microbiol Mol Biol Rev       Date:  2006-12       Impact factor: 11.056

2.  A single mutation in enzyme I of the sugar phosphotransferase system confers penicillin tolerance to Streptococcus gordonii.

Authors:  A Bizzini; J M Entenza; O Michielin; I Arnold; B Erni; P Moreillon
Journal:  Antimicrob Agents Chemother       Date:  2009-10-26       Impact factor: 5.191

3.  Calorimetric and spectroscopic investigation of the interaction between the C-terminal domain of Enzyme I and its ligands.

Authors:  Young-Joo Yun; Jeong-Yong Suh
Journal:  Protein Sci       Date:  2012-09-25       Impact factor: 6.725

4.  Structure of phosphorylated enzyme I, the phosphoenolpyruvate:sugar phosphotransferase system sugar translocation signal protein.

Authors:  Alexey Teplyakov; Kap Lim; Peng-Peng Zhu; Geeta Kapadia; Celia C H Chen; Jennifer Schwartz; Andrew Howard; Prasad T Reddy; Alan Peterkofsky; Osnat Herzberg
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-19       Impact factor: 11.205

5.  Opposing effects of phosphoenolpyruvate and pyruvate with Mg(2+) on the conformational stability and dimerization of phosphotransferase enzyme I from Escherichia coli.

Authors:  Mariana N Dimitrova; Alan Peterkofsky; Ann Ginsburg
Journal:  Protein Sci       Date:  2003-09       Impact factor: 6.725

6.  Dimerization facilitates the conformational transitions for bacterial phosphotransferase enzyme I autophosphorylation in an allosteric manner.

Authors:  Ko On Lee; Young-Joo Yun; Iktae Kim; Jeong-Yong Suh
Journal:  FEBS Open Bio       Date:  2017-07-17       Impact factor: 2.693

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.